Autologous Muscle-Derived Cells for Urinary Sphincter Regeneration: Where are we now?

Conclusions from the pooled analyses indicate that injection of AMDC-USR across a range of dosages appears safe. Efficacy data suggests a dose response with more patients responsive to the higher doses of AMDC-USR.SummaryPromising technologies for utilization of autologous cellular therapies for treatment of SUI, and conceivably multiple additional indications, are approaching fruition. Multiple phase III randomized, placebo-controlled studies for AMDC-USR are ongoing to bring this regenerative option forth for the millions of patients who may ultimately benefit.
Source: Current Bladder Dysfunction Reports - Category: Urology & Nephrology Source Type: research